Neil Woodford’s New Portfolio – In Full!

AstraZeneca plc (LON:AZN), GlaxoSmithKline plc (LON:GSK), Imperial Tobacco Group PLC (LON:IMT), HSBC Holdings plc (LON:HSBA) and British American Tobacco Plc (LON:BATS) feature prominently.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Pound CoinsAce City investor Neil Woodford has published the full list of holdings of his recently launched CF Woodford Equity Income Fund.

Most funds, including Woodford’s old Invesco Perpetual High Income Fund, only give a complete list of holdings twice a year. But Woodford plans to publish the full portfolio every month, and is to be applauded for his transparency.

Similarities

Ahead of the launch of his new fund, Woodford said he intended to run it very much along the same lines as his previous Invesco funds. Woodford watchers will find many familiar names in the new portfolio. Most of the top 10 holdings, for example, match the top 10 in Woodford’s last Invesco Perpetual High Income Fund annual report.

Pharmaceuticals firms AstraZeneca (LSE: AZN) and GlaxoSmithKline (LSE: GSK) continue to dominate with 8.3% and 7.1% weightings respectively, and are joined in the top 10 by Swiss group Roche.

If you fancy following Woodford’s judgement on AstraZeneca and GlaxoSmithKline, the former is trading on around 18 times forecast earnings with a yield of 3.8%, while the latter trades on 15 times forecast earnings with a 5.2% yield.

Tobacco is another sector on which Woodford has been a long-time bull. Old favourites British American Tobacco (LSE: BATS) and Imperial Tobacco (LSE: IMT) are also prominent in the new fund with weightings of 6.2% and 5.2% respectively. They are joined in the top 10 by US group Reynolds American.

British American Tobacco is trading on 17 times forward earnings with a yield of 4%, while Imperial Tobacco trades on 13 times forecast earnings with a 5% yield.

Position
Company Sector Weighting
1 AstraZeneca Healthcare 8.3%
2 GlaxoSmithKline Healthcare 7.1%
3 British American Tobacco Consumer Goods 6.2%
4 BT Telecommunications 6%
5 Imperial Tobacco Consumer Goods 5.3%
6 Roche Healthcare 3.9%
7 Imperial Innovations Financials 3.6%
8 Reynolds American Consumer Goods 3.6%
9 Rolls-Royce Industrials 3.5%
10 Capita Industrials 3.4%
11 Allied Minds Financials 2.9%
12 BAE Systems Industrials 2.9%
13 HSBC Financials 2.8%
14 Sanofi Healthcare 2.3%
15 Legal & General Financials 2.1%
16 Novartis Healthcare 2%
17 Centrica Utilities 2%
18 AA Consumer Services 1.9%
19 SSE Utilities 1.8%
20 Reckitt Benckiser Consumer Goods 1.8%
21 Philip Morris International Consumer Goods 1.8%
22 Prothena Healthcare 1.7%
23 Next Consumer Services 1.7%
24 Altria Consumer Goods 1.3%
25 Smith & Nephew Healthcare 1.3%
26 BTG Healthcare 1.2%
27 Provident Financial Financials 1.1%
28 Drax Utilities 1.1%
29 Alkermes Healthcare 1%
30 Gagfah Financials 1%
31 G4S Industrials 0.97%
32 RM2 International Industrials 0.93%
33 Redde Financials 0.9%
34 Utilitywise Industrials 0.62%
35 Serco Industrials 0.59%
36 Meggitt Industrials 0.59%
37 Lancashire Financials 0.58%
38 Velocys Oil & Gas 0.55%
39 e-Therapeutics Healthcare 0.54%
40 Vernalis Healthcare 0.49%
41 ReNeuron Healthcare 0.48%
42 Cobham Industrials 0.48%
43 Burford Capital Financials 0.44%
44 Catlin Financials 0.43%
45 Benchmark Healthcare 0.43%
46 Amlin Financials 0.43%
47 4D Pharma Healthcare 0.43%
48 Oxford Pharmascience Healthcare 0.35%
49 Revolymer Basic Materials 0.31%
50 Hiscox Financials 0.31%
51 Beazley Financials 0.29%
52 Gigaclear Telecommunications 0.29%
53 Paypoint Industrials 0.25%
54 Homeserve Industrials 0.09%
55 Retroscreen Virology Healthcare 0.09%
56 Xeros Industrials 0.07%
57 NetScientific Healthcare 0.05%
58 IP Financials 0.04%
59 Circassia Healthcare 0.03%
60 Stobart Industrials 0.03%
61 Cranswick Consumer Goods 0.01

Differences

The differences in Woodford’s new fund are perhaps as interesting as the similarities.

For one thing, Woodford had over 100 holdings within his Invesco Perpetual High Income Fund, with a long tail of very small holdings, many of which were obscure little companies, unknown to most investors. The new fund has a smattering of small caps, but is much more focused with a total of 61 holdings.

Furthermore, the new fund holds some companies at a much higher weighting than previously, while there are also a few companies that Woodford never previously held at all.

Imperial Innovations, a company that invests in start-ups founded on research coming out of the UK’s leading universities, has gone from being a 0.5% holding in the Invesco Perpetual High Income Fund to the seventh-largest holding in the new fund with a weighting of 3.6%.

A banks bear since before the financial crisis, Woodford has now re-entered the sector with a 2.8% holding in HSBC (LSE: HSBA), putting the company at number 13 in his portfolio. This global giant trades on just 11 times forecast earnings and offers a prospective income of 5.2%.

Less familiar new entrants that investors may want to take a look at include London-listed American investment company Allied Minds (no. 11 at 2.9%), recently floated roadside recovery firm the AA (no. 18 at 1.9%) and German property group Gagfah (no. 30 at 1.0%).

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool recommends GlaxoSmithKline.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »